ATS 2018 International Conference - Mobile

Improvements in Exacerbation Rate and Lung Function with Weight-Based Intravenous Reslizumab Dosing in Patients with Baseline High Body Weight [Board No. P881]

Location: Board no. P881

Session Type: Thematic Poster Session

Sunday

May

20

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Mirna McDonald

Ms
Teva Pharmaceuticals

Margaret C. Garin

MD
Teva Pharmaceuticals

Kevin R. Murphy

MD
Boys Town National Research Hospital

View Abstract

Improvements in Exacerbation Rate and Lung Function with Weight-Based Intravenous Reslizumab Dosing in Patients with Baseline High Body Weight

Parent Sessions

A34 - ASTHMA CLINICAL STUDIES I
05-20-2018 9:15 AM - 4:15 PM